Management of patients with membranous nephropathy
- 7 July 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (1), 6-9
- https://doi.org/10.1093/ndt/gfr371
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gelDrug Design, Development and Therapy, 2011
- Rituximab Therapy in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2010
- Melanocortin 1 Receptor Agonists Reduce ProteinuriaJournal of the American Society of Nephrology, 2010
- Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2010
- Alkylating agents in membranous nephropathy: efficacy proven beyond doubtNephrology Dialysis Transplantation, 2010
- The Natural History of the Non-Nephrotic Membranous Nephropathy PatientClinical Journal of the American Society of Nephrology, 2009
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent PatientsClinical Journal of the American Society of Nephrology, 2009
- Effects of Rituximab on Morphofunctional Abnormalities of Membranous GlomerulopathyClinical Journal of the American Society of Nephrology, 2008
- Idiopathic membranous nephropathy: Definition and relevance of a partial remissionKidney International, 2004